Delivery of DMAPA-Amp wrapped green fluorescent protein by modified carotid injection
10.3969/j.issn.2095-4344.2014.12.020
- VernacularTitle:改进型颈动脉注射法递送新型基因运载体包裹绿色荧光示踪蛋白
- Author:
Jue WANG
;
Jingnan WANG
;
Yubin DENG
;
Liqun YANG
- Publication Type:Journal Article
- Keywords:
biocompatible materials;
carotid arteries;
injections,intra-arterial;
green fluorescent proteins;
transfection
- From:
Chinese Journal of Tissue Engineering Research
2014;(12):1926-1931
- CountryChina
- Language:Chinese
-
Abstract:
BACKGROUND:Hyperbranched cationic amylopectin is a kind of nonviral gene vectors with low toxicity and good transfection efficiency. However, searching for more efficient methods to delivery it into the body and making the genes expressed are being explored.
OBJECTIVE:To study the expression of DMAPA-Amp wrapped green fluorescent protein (GFP) transferred by modified carotid injection into cerebral ischemic area.
METHODS:Male Sprague-Dawley rats subjected to middle cerebral artery infarction were randomly divided into two groups after 24 hours:experimental group (injected with GFP entrapped DMAPA-Amp via the internal carotid artery) and control group (injected with GFP entrapped DMAPA-Amp via the tail vein). These rats were put to death and their brain tissue was removed after 7 days. The expression of GFP was detected by quantitative PCR and western blot assay, and immunofluorescence staining was performed to detect the expression of GFP located near cerebrovascular endothelial cel s by frozen section.
RESULTS AND CONCLUSION:Compared with the control group, the expression of GFP was much higher in the experimental group detected by quantitative PCR and western blot (P< 0.05). Additional y, the expression of GFP located near cerebrovascular endothelial cel s by frozen section was also higher than that in the control group. Modified carotid injection could significantly promote the expression of hyperbranched cationic amylopectin derivates and GFP in the brain tissue of Sprague-Dawley rats undergoing middle cerebral artery infarction compared with tail vein injection, which indicates DMAPA-Amp and modified carotid injection may cast new lights on the therapy for angiogenesis of ischemic stroke.
